GLYZIMAC OD 30 TABLET

Product Description

GLYZIMAC OD 30 TABLET is a powerful oral anti-diabetic combination therapy, expertly formulated with Gliclazide 30mg and Metformin Hydrochloride 500mg. Designed for once-daily extended-release (OD) dosing, this tablet offers sustained glycemic control for patients with Type 2 Diabetes Mellitus, enhancing insulin sensitivity and reducing blood glucose levels effectively.

Manufactured in WHO-GMP certified facilities, GLYZIMAC OD 30 is ideal for endocrinologists, diabetes care clinics, hospital pharmacies, and bulk pharmaceutical distributors seeking a reliable solution for long-term diabetes management.

Key Benefits:

• Dual mechanism of action for comprehensive blood sugar control

• Gliclazide stimulates insulin secretion

• Metformin improves insulin sensitivity and reduces hepatic glucose production

• Once-daily formulation improves patient compliance

Applications:

• First-line and adjunct therapy for Type 2 Diabetes Mellitus

• Supports glycemic regulation and prevents diabetes-related complications

• Suitable for long-term diabetic treatment protocols

Ideal For:

• Medical wholesalers and retail pharmacy chains

• Hospitals, clinics, and institutional buyers

• PCD pharma franchise and third-party manufacturing inquiries